Consumer Insights
Uncover trends and behaviors shaping consumer choices today
Procurement Insights
Optimize your sourcing strategy with key market data
Industry Stats
Stay ahead with the latest trends and market analysis.
The United States Laparoscopic Devices market was valued at USD 2.46 Billion in 2025 and is expected to grow at a CAGR of 7.90%, reaching USD 5.26 Billion by 2035. The market growth is driven by the increasing adoption of minimally invasive surgical procedures, rising surgical volumes, expanding hospital and ambulatory surgical center infrastructure, and continuous technological advancements in laparoscopic visualization systems, energy-based instruments, and surgical equipment.
Compound Annual Growth Rate
7.9%
Value in USD Billion
2026-2035
Read more about this report - REQUEST FREE SAMPLE COPY IN PDF
Laparoscopic devices comprise specialized instruments and systems designed to facilitate minimally invasive surgical procedures through small incisions, providing an alternative to traditional open surgery. These devices include camera-equipped laparoscopes, light sources, high-definition visualization systems, trocars and access ports, insufflators, graspers, dissectors, scissors, electrosurgical and advanced energy instruments, suction-irrigation equipment, and specimen-retrieval and stapling systems. The market was valued at USD 2.46 Billion in 2025, driven by the growing preference for minimally invasive surgical techniques, rising procedural volumes, improvements in healthcare infrastructure, and continuous technological advancements in laparoscopic equipment.
The following section outlines the key factors influencing the growth of the market, including major drivers, restraints, and emerging opportunities.
Accelerating Adoption of Robotic Assisted Minimally Invasive Surgery and Advanced Surgical Platforms
The principal growth driver is the expanding adoption of robotic-assisted minimally invasive surgery, supported by technological innovation and hospital investment in operating-room efficiency. According to Johnson & Johnson, 2026, FDA authorization of its OTTAVA robotic surgical system expands competition in soft-tissue surgery, including laparoscopic procedures. Medtronic’s US commercial deployment of Hugo RAS at Cleveland Clinic in February 2026 further demonstrates clinical adoption. Economically competitive platform pricing, improved capacity utilization and demand for outpatient procedures incentivize investment in advanced laparoscopic instruments and integrated surgical systems.
High Equipment Acquisition Costs and Limited Reimbursement for Advanced Surgical Technologies
The principal restraint is the high total cost of ownership of advanced laparoscopic and robotic-assisted surgical systems, compounded by constrained hospital budgets and limited reimbursement differentiation. According to the American Hospital Association (2026), hospital expenses increased 7.5% in 2025, while supply expenses rose 9.9%. The American College of Surgeons (2026) highlights that robotic procedures generally incur higher direct costs than conventional laparoscopy without guaranteed additional reimbursement. Consequently, capital rationing, maintenance commitments and uncertain returns on investment can delay equipment upgrades, particularly at smaller hospitals and outpatient facilities.
Expansion of Ambulatory Surgical Centers and Commercialization of Cost-Efficient Robotic-Assisted Platforms
The principal opportunity lies in expanding laparoscopic and robotic-assisted procedures across ambulatory surgical centers (ASCs), supported by evolving reimbursement policies and demand for efficient outpatient care. According to the Centers for Medicare & Medicaid Services (CMS), the 2026 outpatient payment rule expands eligible surgical procedures in ASCs, creating opportunities for compact visualization systems, insufflation equipment and specialized instruments. In April 2026, CMR Surgical announced FDA 510(k) clearance for Versius Plus in cholecystectomy. Economically, modular platforms and recurring instrument revenues offer manufacturers scalable growth while helping providers manage capital expenditure.
Intensifying Competition in Robotic-Assisted Surgery and the Shift Toward Modular Surgical Platforms
The US market is trending toward modular robotic-assisted platforms, integrated visualization and procedure-specific instruments. According to Johnson & Johnson (2026), FDA authorization of its OTTAVA system for multiple upper-abdominal procedures marks a significant expansion of competition in soft-tissue robotics. Medtronic’s June 2026 regulatory submissions for Hugo RAS in general and gynecological surgery further demonstrate portfolio diversification. This competitive shift may improve procurement flexibility, while manufacturers increasingly rely on compatible instruments, service contracts and software ecosystems to sustain recurring revenue amid hospital capital constraints.
Read more about this report - REQUEST FREE SAMPLE COPY IN PDF
Sustained Demand from High-Volume Minimally Invasive Procedures
General surgery remains the leading application, supported by laparoscopic cholecystectomy, appendectomy and hernia repair across US hospitals and ambulatory surgical centers. According to Filardi et al. (2026), contemporary US data demonstrate continued expansion of minimally invasive approaches in emergency cholecystectomy, reinforcing demand for visualization systems, energy devices, access ports and closure instruments. Johnson & Johnson’s July 2026 FDA authorization of OTTAVA for multiple upper-abdominal procedures further strengthens investment in advanced surgical platforms. High procedure volumes support recurring consumables demand and long-term equipment procurement.
The key features of the market report include patent analysis, funding and investment analysis, and strategic initiatives by leading players. The major companies in the market are as follows:
CONMED Corporation is a medical technology company involved in the market. Its product portfolio includes laparoscopic and robotic instruments designed to support minimally invasive surgical procedures. These instruments assist surgeons in performing procedures with precision and control, strengthening the company's presence in the laparoscopic instruments segment.
Karl Storz SE & Co. KG is a medical technology. Its laparoscopic portfolio includes laparoscopes, surgical instruments, imaging systems, and medical devices. The company provides specialized solutions for gynecological laparoscopy, supporting procedures such as hysterectomy, endometriosis treatment, and other minimally invasive surgeries.
B. Braun SE is a medical technology company involved in the United States laparoscopic devices market through its Aesculap minimally invasive surgery portfolio. Its EinsteinVision 3.0 FI system provides real-time 3D fluorescence imaging for laparoscopic procedures. The technology supports tissue perfusion assessment, bile duct visualization, and lymph node mapping, enhancing surgical visualization.
Richard Wolf GmbH is a medical technology company specializing in endoscopic instruments and system solutions for minimally invasive procedures. Its portfolio includes surgical and imaging solutions for disciplines such as general surgery, gynecology, and urology. The company contributes to the market by providing compatible, integrated instruments and equipment that support endoscopic surgical procedures.
Other key players in the market include Medtronic plc., Johnson & Johnson, Olympus Corporation, and Becton, Dickinson and Company.
*Please note that this is only a partial list; the complete list of key players is available in the full report. Additionally, the list of key players can be customized to better suit your needs.*
The market report offers a detailed analysis of the market based on the following segments:
Market Breakup by Product
The product category encompasses visualization systems, surgical instruments, and auxiliary equipment required for minimally invasive procedures. Demand is shaped by improvements in surgical imaging, energy-based tissue dissection, and wound-closure technologies, alongside investments in operating-room infrastructure. Product reliability, interoperability with existing equipment, servicing and maintenance needs, and versatility across different surgical applications remain critical factors influencing purchasing decisions throughout the region.
Market Breakup by Usage
Demand for reusable and disposable laparoscopic instruments is driven by surgical volumes, infection-control requirements, sterilization facilities, and procurement costs. Reusable instruments can be sterilized for repeated use, while disposable instruments are designed for single use, supporting efficient surgical workflows across healthcare facilities.
Market Breakup by Application
Demand across applications is driven by the increasing adoption of minimally invasive surgical techniques across multiple medical specialties. General surgery covers a wide range of procedures, whereas gynecological, colorectal, bariatric, and urological surgeries require application-specific laparoscopic instruments. Adoption is influenced by surgeons’ technical proficiency, patient eligibility, the availability of suitable hospital infrastructure, and access to advanced visualization systems and energy-based surgical technologies.
Market Breakup by End User
Hospitals and clinics constitute major end users, conducting a broad range of surgical procedures across multiple specialties and requiring comprehensive operating-room infrastructure. Ambulatory surgical centers further contribute to market demand by facilitating outpatient surgeries and reducing dependence on extended hospital stays. Procurement decisions are influenced by procedural volumes, capital availability, workforce capacity, equipment utilization rates, and access to adequate sterilization, servicing, and maintenance facilities.
*While we strive to always give you current and accurate information, the numbers depicted on the website are indicative and may differ from the actual numbers in the main report. At Expert Market Research, we aim to bring you the latest insights and trends in the market. Using our analyses and forecasts, stakeholders can understand the market dynamics, navigate challenges, and capitalize on opportunities to make data-driven strategic decisions.*
Explore our key highlights of the report and gain a concise overview of key findings, trends, and actionable insights that will empower your strategic decisions.
| REPORT FEATURES | DETAILS |
| Base Year | 2025 |
| Historical Period | 2019-2025 |
| Forecast Period | 2026-2035 |
| Scope of the Report |
Historical and Forecast Trends, Industry Drivers and Constraints, Historical and Forecast Market Analysis by Segment:
|
| Breakup by Product |
|
| Breakup by Usage |
|
| Breakup by Application |
|
| Breakup by End User |
|
| Market Dynamics |
|
| Supplier Landscape |
|
| Companies Covered |
|
Datasheet
One User
USD 1,999
USD 1,799
tax inclusive*
Single User License
One User
USD 3,099
USD 2,789
tax inclusive*
Five User License
Five User
USD 4,599
USD 3,909
tax inclusive*
Corporate License
Unlimited Users
USD 5,999
USD 5,099
tax inclusive*
*Please note that the prices mentioned below are starting prices for each bundle type. Kindly contact our team for further details.*
Flash Bundle
Small Business Bundle
Growth Bundle
Enterprise Bundle
*Please note that the prices mentioned below are starting prices for each bundle type. Kindly contact our team for further details.*
Flash Bundle
Number of Reports: 3
20%
tax inclusive*
Small Business Bundle
Number of Reports: 5
25%
tax inclusive*
Growth Bundle
Number of Reports: 8
30%
tax inclusive*
Enterprise Bundle
Number of Reports: 10
35%
tax inclusive*
How To Order
Select License Type
Choose the right license for your needs and access rights.
Click on ‘Buy Now’
Add the report to your cart with one click and proceed to register.
Select Mode of Payment
Choose a payment option for a secure checkout. You will be redirected accordingly.
Strategic Solutions for Informed Decision-Making
Gain insights to stay ahead and seize opportunities.
Get insights & trends for a competitive edge.
Track prices with detailed trend reports.
Analyse trade data for supply chain insights.
Leverage cost reports for smart savings
Enhance supply chain with partnerships.
Connect For More Information
Our expert team of analysts will offer full support and resolve any queries regarding the report, before and after the purchase.
Our expert team of analysts will offer full support and resolve any queries regarding the report, before and after the purchase.
We employ meticulous research methods, blending advanced analytics and expert insights to deliver accurate, actionable industry intelligence, staying ahead of competitors.
Our skilled analysts offer unparalleled competitive advantage with detailed insights on current and emerging markets, ensuring your strategic edge.
We offer an in-depth yet simplified presentation of industry insights and analysis to meet your specific requirements effectively.